UPC Analytics
ENDE
Overview · Filed: Sep 30, 2024

UPC_CFI_497/2024

MODULAR POINT-OF-CARE DEVICES AND USES THEREOF

RevocationMain Revocation ActionMilan CDRevocationCase Closed
Parties

Claimants

  • bioMérieux UK Limited
Reps: Benjamin Husband

Respondents

  • Labrador Diagnostics LLC
Reps: Christof Höhne
Judges
  • Andrea Postiglione
  • Marije Knijff
  • Michel Abello
Patents
  • EP3756767
CPC codes: B01L3/021, G01N2333/4737, G01N2035/00851, G01N2333/71, G01N33/48, B01J2219/00292, B01L7/5255, B01L9/543, B01L7/52, A61B5/151, G01N33/54366, A61B10/0058

Technology area: Medical Devices · Diagnostics

Sector: Biotechnology

Outcome
Patent amendedMaintained as amended
Filed: Sep 30, 2024
First decided: Oct 23, 2025
Language: English

The Central Division Milan rejected the revocation action by bioMérieux against Labrador Diagnostics' EP 3 756 767 B1 (diagnostic test patent), maintaining the patent in amended form pursuant to Auxiliary Request 3; bioMérieux was ordered to pay EUR 400,000 in legal costs to Labrador.

Open on UPC Registry
Claims
At issueall
Maintainedall
Amendedall
Notes: Revocation action rejected; EP 3 756 767 maintained as amended by Auxiliary Request 3; specific amended claim numbers not enumerated in excerpt.